Heterozygous Arg753Gln Polymorphism of Human TLR-2 Impairs Immune Activation by Borrelia burgdorferi and Protects from Late Stage Lyme Disease
Nicolas W.J. Schröder,Isabel Diterich,Antje Zinke,Jana Eckert,Christian Draing,Volker von Baehr,Dieter Hassler,Susanne Priem,Katrin Hahn,Kathrin S. Michelsen,Thomas Hartung,Gerd R Burmester,Ulf B. Göbel,Corinna Hermann,Ralf R. Schumann +14 more
Reads0
Chats0
TLDR
It is shown that TNF-α induction by Borrelia lysate was impaired in heterozygous TLR-2 knockout mice, while reactivity to lipoteichoic acid, another TLR -2 ligand signaling via TLr-2/TLR-6 heterodimers, was unaffected, suggesting that Arg753Gln may protect from the development of late stage LD due to a reduced signaling viaTLR/TLr-1.Abstract:
Lyme disease (LD) is caused by Borrelia burgdorferi and displays different stages, including localized, early disseminated, and persistent infection, all of which are associated with profound inflammatory reactions in the host. Induction of proinflammatory cytokines by B. burgdorferi is mainly mediated by outer surface proteins interacting with TLR-2/TLR-1 heterodimers. In this study, we show that TNF-alpha induction by Borrelia lysate was impaired in heterozygous TLR-2 knockout mice, while reactivity to lipoteichoic acid, another TLR-2 ligand signaling via TLR-2/TLR-6 heterodimers, was unaffected. Blood from individuals heterozygous for the TLR-2 polymorphism Arg753Gln was tested for cytokine release upon stimulation with Borrelia lysate, and induction of TNF-alpha and IFN-gamma was significantly lower as compared with individuals not exhibiting this variation. Overexpression of TLR-2 carrying the Arg753Gln polymorphism in HEK 293 cells led to a significantly stronger impairment of activation by TLR-2/TLR-1 ligands as compared with TLR-2/TLR-6 ligands. To study whether heterozygosity for the Arg753Gln variant of TLR-2 influenced susceptibility for LD, we analyzed 155 patients for this polymorphism. The Arg753Gln variant occurs at a significantly lower frequency in LD patients as compared with matched controls (5.8 vs 13.5%, odds ratio 0.393, 95% confidence interval 0.17-0.89, p = 0.033), with an even more pronounced difference when late stage disease was observed (2.3 vs 12.5%, odds ratio 0.163, 95% confidence interval 0.04-0.76, p = 0.018). These data suggest that Arg753Gln may protect from the development of late stage LD due to a reduced signaling via TLR-2/TLR-1.read more
Citations
More filters
Journal ArticleDOI
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
TL;DR: This review presents current knowledge on pathogen recognition through different families of PRRs and the increasingly complex signaling pathways responsible for activation of an inflammatory and antimicrobial response and medical implications are discussed.
Journal ArticleDOI
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
TL;DR: Recent advances in the understanding of signaling pathways activated by TLRs, structural insights into TLRs bound to their ligands and antagonists, and approaches to inhibit TLRs are providing possible means by which to interfere with TLRs clinically.
Journal ArticleDOI
Human TLRs and IL-1Rs in Host Defense: Natural Insights from Evolutionary, Epidemiological, and Clinical Genetics
TL;DR: A careful reconsideration of the contributions of TLRs and IL-1Rs to host defense in natura is required.
Journal ArticleDOI
Toll-like receptor polymorphisms and susceptibility to human disease
E. Ann Misch,Thomas R. Hawn +1 more
TL;DR: A review of studies of common TLR polymorphisms and how this work is beginning to illuminate the influence of human variation on inflammation and disease susceptibility can be found in this paper, where the authors summarize studies of these polymorphisms, and conclude that some of them are associated with susceptibility to a spectrum of diseases.
Journal ArticleDOI
Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy
Christopher M. Johnson,Elizabeth A. Lyle,Katherine O. Omueti,Vitaly Stepensky,Olcay Yegin,Erkan Alpsoy,Lutz Hamann,Ralf R. Schumann,Richard I. Tapping +8 more
TL;DR: Surprisingly, the 602S allele represents the most common single nucleotide polymorphism affecting TLR function identified to date and is associated with a decreased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.
References
More filters
Journal ArticleDOI
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
Adrian Ozinsky,David M. Underhill,Jason D. Fontenot,Adeline M. Hajjar,Kelly D. Smith,Christopher B. Wilson,Lea Schroeder,Alan Aderem +7 more
TL;DR: The data suggest that TLRs sample the contents of the phagosome independent of the nature of the contents, and can establish a combinatorial repertoire to discriminate among the large number of pathogen-associated molecular patterns found in nature.
Journal ArticleDOI
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.
Nancy C. Arbour,Eva Lorenz,Brian C. Schutte,Joseph Zabner,Joel N. Kline,Michael P. Jones,Kathy L. Frees,Janet L. Watt,David A. Schwartz +8 more
TL;DR: These findings provide the first genetic evidence that common mutations in TLR4 are associated with differences in LPS responsiveness in humans, and demonstrate that gene-sequence changes can alter the ability of the host to respond to environmental stress.
Journal ArticleDOI
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
Hans Brightbill,Daniel H. Libraty,Stephan R. Krutzik,Ruey-Bing Yang,John T. Belisle,Joshua R. Bleharski,Michael Maitland,Michael V. Norgard,Scott E. Plevy,Stephen T. Smale,Patrick J. Brennan,Barry R. Bloom,Barry R. Bloom,Paul J. Godowski,Robert L. Modlin +14 more
TL;DR: It is shown that microbial lipoproteins are potent stimulators of IL-12 production by human macrophages, and that induction is mediated by Toll-like receptors (TLRs), and that Activation of TLRs by microbes may initiate innate defense mechanisms against infectious pathogens.
Journal ArticleDOI
Discrimination of bacterial lipoproteins by Toll-like receptor 6
Osamu Takeuchi,Taro Kawai,Peter F. Mühlradt,Michael Morr,Justin D. Radolf,Arturo Zychlinsky,Kiyoshi Takeda,Shizuo Akira +7 more
TL;DR: Results show that TLR6 recognizes MALP-2 cooperatively with TLR2, and appears to discriminate between the N-terminal lipoylated structures of MALp-2 and lipopeptides derived from other bacteria.
Journal ArticleDOI
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Stefan Kiechl,Eva Lorenz,Markus Reindl,Christian J. Wiedermann,Friedrich Oberhollenzer,Enzo Bonora,Johann Willeit,David A. Schwartz +7 more
TL;DR: The Asp299Gly TLR4 polymorphism, which attenuates receptor signaling and diminishes the inflammatory response to gram-negative pathogens, is associated with a decreased risk of atherosclerosis, consistent with the hypothesis that innate immunity may play a part in atherogenesis.